Search

Search Constraints

You searched for: Author/Creator Carducci, M.

Search Results

1. 4BA A phase 3, randomized, double-blind, placebo-controlled study of tasquinimod (TASQ) in men with metastatic castrate resistant prostate cancer (mCRPC). (September 2015)

3. Bone turnover biomarkers identify unique prognostic risk groups in men with castration resistant prostate cancer and skeletal metastases: Results from SWOG S0421. (2018)

4. Debridement, antibiotics and implant retention (DAIR): An effective treatment option for early prosthetic joint infections. Issue 8 (August 2021)

5. OC-0505: Interim results of a randomized trial of observation versus SABR for oligometastatic prostate cancer. (April 2018)